Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
85.89 USD | -0.59% |
|
-4.99% | -13.34% |
09:29am | HSBC Adjusts Price Target on Merck to $115 From $130 | MT |
07:59am | Merck Says Health Canada Approves Keytruda for Non-Small Cell Lung Cancer | MT |
MarketScreener Strategies
![]() | Merck & Co, Inc: A cash cow that hides some gems | July 18, 2022 at 06:12 am EDT |
Merck and Company : Leader in oncology, modest valuation | October 29, 2019 at 11:04 am EDT |
- Stock Market
- Equities
- MRK Stock
- News Merck & Co., Inc.
- MarketScreener Strategies